Kazia Therapeutics Ltd ADR
Price & Volume
Stats
See more52W Range | $2.86-$26.30 |
Market Cap | $17.6M |
Shares Short | 12,176 |
Financials
See moreRevenue (12 Mos) | $1.8M |
Revenue Growth (YoY) | -27.2% |
Gross Profit (12 Mos) | $1.8M |
Diluted EPS | -$12.35 |
News
See moreYahoo Finance • 12 days ago
Nuclear Power Surge, $10M Buyback, and a $1.9B SEO Bombshell
Yahoo Finance • 3 months ago
Discover the top movers in Thursday's pre-market session.
Yahoo Finance • 2 years ago
KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
Yahoo Finance • 3 years ago
KAZIA PRESENTS NEW DATA FOR PAXALISIB AND EVT801 AT AACR ANNUAL MEETING
About
Address | Three International Towers, Sydney, NSW, Australia, 2000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
